Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Apr;44(4):672–688. doi: 10.1111/j.1476-5381.1972.tb07306.x

Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation

María A Enero, S Z Langer, R P Rothlin, F J E Stefano
PMCID: PMC1665979  PMID: 4339385

Abstract

1. A study of the actions of phenoxybenzamine on transmitter overflow, neuronal and extraneuronal uptake of noradrenaline and in causing α-adrenoceptor blockade was carried out using the isolated cat nictitating membrane preparation.

2. Phenoxybenzamine increased transmitter overflow elicited by nerve-stimulation at 10 Hz in a concentration dependent manner in the range 10-8 to 10-5 g/ml.

3. Neuronal uptake of [3H]-noradrenaline was not inhibited by concentrations lower than 10-6 g/ml of phenoxybenzamine. With 10-7 g/ml of phenoxybenzamine a significant increase in transmitter overflow was obtained, although neuronal uptake of noradrenaline was not affected. Higher concentrations of phenoxybenzamine (10-6 and 10-5 g/ml) inhibited the neuronal uptake of noradrenaline and further increased transmitter overflow.

4. Extraneuronal uptake of [3H]-noradrenaline was inhibited only with the highest concentration of phenoxybenzamine tested (10-5 g/ml) and therefore appears to be unrelated to the effects on transmitter overflow.

5. There was a significant correlation between the degree of α-adrenoceptor block produced by phenoxybenzamine and the increase in transmitter overflow obtained by nerve stimulation.

6. These results indicate that phenoxybenzamine, in addition to increasing overflow by preventing reuptake of noradrenaline, may increase transmitter release.

7. The possibility that phenoxybenzamine acts on α-adrenoceptors in the adrenergic nerve terminal is discussed. These receptors would be involved in a negative feedback mechanism regulating transmitter release.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avakian O. V., Gillespie J. S. Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Br J Pharmacol Chemother. 1968 Jan;32(1):168–184. doi: 10.1111/j.1476-5381.1968.tb00441.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLAKELEY A. G., BROWN G. L., FERRY C. B. Pharmacological experiments on the release of the sympathetic transmitter. J Physiol. 1963 Jul;167:505–514. doi: 10.1113/jphysiol.1963.sp007165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BROWN G. L., GILLESPIE J. S. The output of sympathetic transmitter from the spleen of the cat. J Physiol. 1957 Aug 29;138(1):81–102. doi: 10.1113/jphysiol.1957.sp005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bell C., Vogt M. Release of endogenous noradrenaline from an isolated muscular artery. Release of endogenous noradrenaline from an isolated muscular artery. J Physiol. 1971 Jun;215(2):509–520. doi: 10.1113/jphysiol.1971.sp009482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boullin D. J., Costa E., Brodie B. B. Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation. J Pharmacol Exp Ther. 1967 Jul;157(1):125–134. [PubMed] [Google Scholar]
  6. CROUT J. R. THE UPTAKE AND RELEASE OF H3-NOREPINEPHRINE BY THE GUINEA-PIG HEART IN VIVO. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Apr 21;248:85–98. doi: 10.1007/BF00247061. [DOI] [PubMed] [Google Scholar]
  7. Draskóczy P. R., Trendelenburg U. Intraneuronal and extraneuronal accumulation of sympathomimetic amines in the isolated nictitating membrane of the cat. J Pharmacol Exp Ther. 1970 Aug;174(2):290–306. [PubMed] [Google Scholar]
  8. Ferry C. B. The autonomic nervous system. Annu Rev Pharmacol. 1967;7:185–202. doi: 10.1146/annurev.pa.07.040167.001153. [DOI] [PubMed] [Google Scholar]
  9. Folkow B., Häggendal J., Lisander B. Extent of release and elimination of noradrenaline at peripheral adrenergic nerve terminals. Acta Physiol Scand Suppl. 1967;307:1–38. [PubMed] [Google Scholar]
  10. HERTING G., AXELROD J., WHITBY L. G. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther. 1961 Nov;134:146–153. [PubMed] [Google Scholar]
  11. Haefely W., Hürlimann A., Thoenen H. Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J Physiol. 1965 Nov;181(1):48–58. doi: 10.1113/jphysiol.1965.sp007744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Häggendal J., Malmfors T. The effect of nerve stimulation on the uptake of noradrenaline into the adrenergic nerve terminals. Acta Physiol Scand. 1969 Jan-Feb;75(1):28–32. doi: 10.1111/j.1748-1716.1969.tb04351.x. [DOI] [PubMed] [Google Scholar]
  13. IVERSEN L. L. THE UPTAKE OF NORADRENALINE BY THE ISOLATED PERFUSED RAT HEART. Br J Pharmacol Chemother. 1963 Dec;21:523–537. doi: 10.1111/j.1476-5381.1963.tb02020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iversen L. L., Langer S. Z. Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol. 1969 Nov;37(3):627–637. doi: 10.1111/j.1476-5381.1969.tb08501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kirpekar S. M., Wakade A. R. Effect of beta-haloalkylamines and ephedrine on noradrenaline release from the intact spleen of the cat. Br J Pharmacol. 1970 Jul;39(3):533–541. doi: 10.1111/j.1476-5381.1970.tb10361.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Langer S. Z., Draskóczy P. R., Trendelenburg U. Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J Pharmacol Exp Ther. 1967 Aug;157(2):255–273. [PubMed] [Google Scholar]
  17. Langer S. Z. The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J Physiol. 1970 Jul;208(3):515–546. doi: 10.1113/jphysiol.1970.sp009135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Langer S. Z., Trendelenburg U. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther. 1969 May;167(1):117–142. [PubMed] [Google Scholar]
  19. Langer S. Z., Vogt M. Noradrenaline release from isolated muscles of the nictitating membrane of the cat. J Physiol. 1971 Apr;214(1):159–171. doi: 10.1113/jphysiol.1971.sp009425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Laverty R., Taylor K. M. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal Biochem. 1968 Feb;22(2):269–279. doi: 10.1016/0003-2697(68)90316-3. [DOI] [PubMed] [Google Scholar]
  21. Lightman S. L., Iversen L. L. The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol. 1969 Nov;37(3):638–649. doi: 10.1111/j.1476-5381.1969.tb08502.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Löffelholz K., Muscholl E. A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(1):1–15. doi: 10.1007/BF01417206. [DOI] [PubMed] [Google Scholar]
  23. ROSELL S., KOPIN I. J., AXELROD J. FATE OF H3-NORADRENALINE IN SKELETAL MUSCLE BEFORE AND FOLLOWING SYMPATHETIC STIMULATION. Am J Physiol. 1963 Aug;205:317–321. doi: 10.1152/ajplegacy.1963.205.2.317. [DOI] [PubMed] [Google Scholar]
  24. THOMPSON J. W. Studies on the responses of the isolated nictitating membrane of the cat. J Physiol. 1958 Apr 3;141(1):46–72. doi: 10.1113/jphysiol.1958.sp005954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thoenen H., Hürlimann A., Haefely W. Dual site of action of phenoxybenzamine in the cat's spleen; blockade of alpha-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia. 1964 May 15;20(5):272–273. doi: 10.1007/BF02151802. [DOI] [PubMed] [Google Scholar]
  26. Trendelenburg U., Draskóczy P. R., Pluchino S. The density of adrenergic innervation of the cat's nictitating membrane as a factor influencing the sensitivity of the isolated preparation to l-norepinephrine. J Pharmacol Exp Ther. 1969 Mar;166(1):14–25. [PubMed] [Google Scholar]
  27. Trendelenburg U. Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev. 1966 Mar;18(1):629–640. [PubMed] [Google Scholar]
  28. Van Orden L. S., 3rd, Bensch K. G., Langer S. Z., Trendelenburg U. Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat. J Pharmacol Exp Ther. 1967 Aug;157(2):274–283. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES